Global
About
Development milestones Mission&Vision Founder Research Achievement
Technology Platforms
Single domain antibody Five core technology platforms
PIPELINE
BUSINESS PARTNERSHIPS
Product Out-Licensing Co-Development
INVESTORS
CAREERS
Our Story Social Recruitment
News
Company News Media
Contact Us
Company Address Online Message
×
Our Story

Share the latest information

Our Story
News
Company News
Media
2026-03-13
Novamab Announces China Phase Ⅱ Clinical Trial Approval for First-in-Class Inhaled IL-4Rα VHH Antibody LQ036 Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD)
More
2021-10-18
The fourth anniversary celebration of Novamab was successfully held!
More
2021-10-11
Novamab announced that its anti-IL-4R VHH antibody LQ036 clinical phase I study completed the first subject administration!
More
2021-06-29
Novamab has been recognized as a pilot patent enterprise in Shanghai!
More
2021-04-08
Novamab has obtained tens of millions of A+rounds of financing!
More
2021-03-12
Novamab has completed a round of financing of billion yuan!
More
2021-03-08
Rocky Biology has obtained the high-tech enterprise certificate!
More
2020-12-08
Novamab won two honors!
More
2020-10-16
We will work together and forge ahead - the third anniversary of the founding of Novamab
More
2020-09-17
Novamab won the recognition of high-tech enterprises in Shanghai!
More
2019-11-22
The joint research results of Novamab and Peking University Cancer Hospital in nuclear medicine were published online in the international journal BIOCONJUGATE CHEMISTRY
More
Total 55 123456